Compare Summit Therapeutics Inc (SMMT) vs TAL Education Group American Depositary Shares (TAL) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Summit Therapeutics Inc vs TAL Education Group American Depositary Shares — how do they compare? Summit Therapeutics Inc trades at $17.6 (market cap $13.71B), while TAL Education Group American Depositary Shares trades at $12.91 (market cap $6.93B). The key difference: Summit Therapeutics Inc is the larger of the two by market cap, and TAL Education Group American Depositary Shares is trading nearer its 52-week high, Summit Therapeutics Inc nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Summit Therapeutics Inc for 16 Days and TAL Education Group American Depositary Shares for 0 Days on average.
| SMMT | TAL | |
|---|---|---|
Market Cap | $13.71B | $6.93B |
Volume | 6,173,057 | 2,470,140 |
Sector | Health | Consumer Staples |
52-Week High | $26.38 | $12.91 |
52-Week Low | $12.43 | $8.95 |
Typical Hold Time | 16 Days | 0 Days |
Enterprise Value | $13.04B | $4.46B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Summit Therapeutics (SMMT) trades at $17.95, up 3.7% with strong technical momentum and bullish analyst sentiment. The stock shows negative profitability metrics but benefits from AstraZeneca's $2 billion strategic investment and clinical collaborations. Recent news highlights positive clinical trial results for ivonescimab, driving investor optimism despite current financial losses.
The outlook remains speculative with significant upside potential based on analyst consensus targets averaging $29.33, though high valuation multiples and negative cash flows present substantial risk. Success of clinical trials and partnership execution will determine long-term value creation for shareholders.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Summit Therapeutics Inc
Summit Therapeutics Inc. is a biopharmaceutical company focused on the development and commercialization of new medicines for the treatment of infectious diseases and other unmet medical needs. The company's lead product candidate is an antibiotic for the treatment of Clostridioides difficile infection (CDI), a serious infection of the colon. Summit Therapeutics is committed to bringing innovative therapies to market to address global health challenges and improve patient outcomes.
Read more on SMMT →About TAL Education Group American Depositary Shares
TAL Education Group provides smart learning solutions in China. Its offerings combine teaching content, technology, and learning services through various online and offline formats.
Read more on TAL →
